426 related articles for article (PubMed ID: 26781137)
21. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T.
Xu XQ; Hu H; Liu H; Wu JF; Cao P; Shi HB; Wu FY
J Magn Reson Imaging; 2017 Jan; 45(1):167-176. PubMed ID: 27299917
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions.
Cao J; Xiao L; He B; Zhang G; Dong J; Wu Y; Xie H; Wang G; Lin X
Clin Radiol; 2017 Sep; 72(9):793.e1-793.e9. PubMed ID: 28545685
[TBL] [Abstract][Full Text] [Related]
23. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
Yuan Y; Kuai XP; Chen XS; Tao XF
Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
[TBL] [Abstract][Full Text] [Related]
24. The roles of the diffusion-weighted imaging in orbital masses.
Phuttharak W; Boonrod A; Patjanasoontorn N; Peansukwech U; Sawanyawisuth K
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):753-758. PubMed ID: 28664638
[TBL] [Abstract][Full Text] [Related]
25. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
26. How to manage type 2 curve dilemma in dynamic contrast-enhanced magnetic resonance imaging of the breast: diffusion-weighted imaging or early phase enhancement kinetics?
Ulu Öztürk F; Tezcan Ş; Uslu N
Acta Radiol; 2024 Apr; 65(4):341-349. PubMed ID: 38193154
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of focal indeterminate marrow abnormalities with multiparametric MRI.
Baik JS; Jung JY; Jee WH; Chun CW; Kim SK; Shin SH; Chung YG; Jung CK; Kannengiesser S; Sohn Y
J Magn Reson Imaging; 2017 Jul; 46(1):49-60. PubMed ID: 27859835
[TBL] [Abstract][Full Text] [Related]
28. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
29. Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI.
Yabuuchi H; Kamitani T; Sagiyama K; Yamasaki Y; Hida T; Matsuura Y; Hino T; Murayama Y; Yasumatsu R; Yamamoto H
Eur Radiol; 2020 Dec; 30(12):6402-6412. PubMed ID: 32613285
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study.
Pinker K; Baltzer P; Bogner W; Leithner D; Trattnig S; Zaric O; Dubsky P; Bago-Horvath Z; Rudas M; Gruber S; Weber M; Helbich TH
Radiology; 2015 Aug; 276(2):360-70. PubMed ID: 25751227
[TBL] [Abstract][Full Text] [Related]
31. Comparison of intravoxel incoherent motion diffusion-weighted MR imaging with dynamic contrast-enhanced MRI for differentiating lung cancer from benign solitary pulmonary lesions.
Yuan M; Zhang YD; Zhu C; Yu TF; Shi HB; Shi ZF; Li H; Wu JF
J Magn Reson Imaging; 2016 Mar; 43(3):669-79. PubMed ID: 26340144
[TBL] [Abstract][Full Text] [Related]
32. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric MR imaging with diffusion-weighted, intravoxel incoherent motion, diffusion tensor, and dynamic contrast-enhanced perfusion sequences to assess gallbladder wall thickening: a prospective study based on surgical histopathology.
Kalage D; Gupta P; Gulati A; Yadav TD; Gupta V; Kaman L; Nada R; Singh H; Irrinki S; Gupta P; Das C; Dutta U; Sandhu M
Eur Radiol; 2023 Jul; 33(7):4981-4993. PubMed ID: 36826499
[TBL] [Abstract][Full Text] [Related]
34. Differentiating between benign and malignant sinonasal lesions using dynamic contrast-enhanced MRI and intravoxel incoherent motion.
Jiang J; Xiao Z; Tang Z; Zhong Y; Qiang J
Eur J Radiol; 2018 Jan; 98():7-13. PubMed ID: 29279173
[TBL] [Abstract][Full Text] [Related]
35. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
[TBL] [Abstract][Full Text] [Related]
36. MRI of Pediatric Orbital Masses: Role of Quantitative Diffusion-weighted Imaging in Differentiating Benign from Malignant Lesions.
Jaju A; Rychlik K; Ryan ME
Clin Neuroradiol; 2020 Sep; 30(3):615-624. PubMed ID: 31134316
[TBL] [Abstract][Full Text] [Related]
37. The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses.
Choi SY; Kim SH; Jang KM; Kang TW; Song KD; Moon JY; Choi YH; Lee BR
Br J Radiol; 2016 Jul; 89(1063):20160054. PubMed ID: 27164031
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
Kuang F; Yan Z; Li H; Feng H
J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.
Jeon JY; Chung HW; Lee MH; Lee SH; Shin MJ
Br J Radiol; 2016; 89(1060):20150929. PubMed ID: 26892266
[TBL] [Abstract][Full Text] [Related]
40. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient.
Cao Y; Wang X; Shi J; Zeng X; Du L; Li Q; Nickel D; Zhou X; Zhang J
Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
